MEPS Statistical Brief No.514: Reported Diagnosis & Prescription Utilization Related To Attention Deficit Hyperactivity Disorder In Children Ages 5-17, 2008-2015
The study was released in August 2018 by the Agency for Healthcare Research and Quality (AHRQ). The researcher analyzed data from the Medical Expenditure Panel Survey Household Component (MEPS-HC) for 2008 and 2015 for children ages 5 to 17 diagnosed with attention deficit/hyperactivity disorder (ADHD). The goal was to determine diagnosis trends for younger (ages 5 to 12) and older children (ages 13 to 17), and trends in pharmaceutical treatment for ADHD . . .

